Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Receivables (2016 - 2021)

Vistagen Therapeutics' Receivables history spans 4 years, with the latest figure at $81200.0 for Q1 2021.

  • For Q1 2021, Receivables changed N/A year-over-year to $81200.0; the TTM value through Mar 2021 reached $81200.0, changed N/A, while the annual FY2021 figure was $81200.0, N/A changed from the prior year.
  • Receivables for Q1 2021 was $81200.0 at Vistagen Therapeutics, down from $1.2 million in the prior quarter.
  • Across five years, Receivables topped out at $81200.0 in Q1 2021 and bottomed at $81200.0 in Q1 2021.